HAPLN1 is a driver for peritoneal carcinomatosis in pancreatic cancer

Lena Wiedmann(BioNTech (Germany)), Juan Rodríguez‐Vita(Cancer Research Center)

bioRxiv (Cold Spring Harbor Laboratory)

May 30, 2022

10.1101/2022.05.30.493185

Cited by 3

Related Papers

HAPLN1 potentiates peritoneal metastasis in pancreatic cancer

|Nature Communications|2023|50